Development and Preclinical Evaluation of a Lyophilized Vaccine Against Equine Herpesvirus Type 4 (EHV-4)
This freeze-dried, live-attenuated EHV-4 vaccine candidate is safe, immunogenic, and thermostable. It offers a promising platform for the targeted prevention of EHV-4 infection, particularly in young horses and in regions with limited cold-chain infrastructure.
Authors
- Кутумбетов Леспек Бекболатович (ORCID: https://orcid.org/0000-0001-8481-0673)
- Balzhan Sh. Myrzakhmetova (ORCID: https://orcid.org/0000-0002-4141-7174)
- Aslan Kerimbayev (ORCID: https://orcid.org/0000-0002-9387-6647)
- Sergazy Sh. Nurabayev (ORCID: https://orcid.org/0000-0003-0843-1983)
- K.B. Bissenbayeva (ORCID: https://orcid.org/0000-0001-5788-6074)
- Г.А. Жаппарова (ORCID: https://orcid.org/0000-0001-5382-831X)
- Aiganym Tussipova (ORCID: https://orcid.org/0000-0002-7767-0542)
- T.M. Tlenchiyeva (ORCID: https://orcid.org/0009-0006-7831-4212)
Publication Details
- Journal
- Vaccines
- Published
- 2025-05-31
- DOI
- https://doi.org/10.3390/vaccines13060604
- Citations
- 1
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.35